Form D · Pharmaceuticals
Inventure, LLC
Southbury, CT · CIK 0001706556
Offering snapshot reported Sep 3, 2026 · SEC filing
- Reported sold
- $82.3K Offering amount: $82.3K
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $7.35K Reported outside-investor minimum
- First sale
- Aug 31, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 3, 2026 | Initial | $82,345 | No comparison | 4 | SEC filing |
| Feb 23, 2026 | Initial | $200,000 | No comparison | 4 | SEC filing |
| Jul 10, 2025 | Initial | $361,500 | No comparison | 6 | SEC filing |
| Aug 25, 2023 | Initial | $250,000 | No comparison | 5 | SEC filing |
| Mar 15, 2023 | Initial | $2,100,000 | No comparison | 5 | SEC filing |
| Sep 29, 2021 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Jan 11, 2021 | Initial | $45,000 | No comparison | 8 | SEC filing |
| Jan 11, 2021 | Amendment | $45,000 | $0vs Jan 11, 2021 | 8 | SEC filing |
| Mar 20, 2020 | Amendment | $350,000 | -$75,000vs Mar 19, 2020 | 9 | SEC filing |
| Mar 19, 2020 | Initial | $425,000 | No comparison | 9 | SEC filing |
| Oct 21, 2019 | Amendment | $175,045 | No comparison | 7 | SEC filing |
| Sep 5, 2019 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jul 9, 2019 | Initial | $125,000 | No comparison | 1 | SEC filing |
| Jun 6, 2019 | Initial | $200,000 | No comparison | 8 | SEC filing |
| May 22, 2017 | Initial | $1,199,000 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-596340
Source: Form D, filed Sep 3, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jonathan Balfour | Executive |
| Richard Deslauriers | Director |
| Bill Doyle | Director, Executive |
| William F. Doyle | Director |
| Robert F. Jacobs | Executive |
| Richard Rosene | Director, Executive |
| Brad Rummer | Director |
| Kyle Salem | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
25 Depot Hill Road Building One, Suite 104
Southbury, CT, 06488
Phone: 2039824239
Southbury, CT, 06488
Phone: 2039824239